Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers

被引:22
|
作者
Vena, Gino A. [1 ]
Cassano, Nicoletta [1 ]
Coco, Valeria [2 ]
De Simone, Clara [2 ]
机构
[1] Univ Bari, Dept Biomed Sci & Human Oncol, Unit Dermatol & Venereol, I-70124 Bari, Italy
[2] Univ Cattolica Sacro Cuore, Unit Dermatol, I-00168 Rome, Italy
关键词
Antihypertensive drugs; cutaneous adverse drug reactions; drug-induced dermatitis; eczema; hydrochlorothiazide; CAPTOPRIL; DRUG; SURVEILLANCE; BRADYKININ; IRBESARTAN; ERUPTION;
D O I
10.3109/08923973.2013.797992
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cutaneous adverse drug reactions (ADRs) to antihypertensive drugs have been frequently reported. We describe a peculiar clinical pattern of cutaneous ADR, represented by an eczematous reaction induced by certain antihypertensive drugs that we observed in elderly patients. The case series consisted of 23 hypertensive patients aged 66-87 years; 19 of them were taking another drug in addition to the suspected antihypertensive medication and 15 were on polytherapy with three or more drugs to treat multiple comorbidities. The antihypertensive culprit agents were angiotensin-converting enzyme (ACE) inhibitors in 9 patients, ACE-inhibitors combined to hydrochlorothiazide (HCT) in 7 subjects, angiotensin II receptor blockers alone in 2 patients and associated with HCT in 5 cases. The cutaneous ADR was characterized by an eczematous rash that was generalized in 16 patients and localized in 7 cases, with predominant involvement of lower limbs. Such lesions developed after a latency of 4-30 months and were associated with moderate-to-severe itch, usually unresponsive to oral antihistamines. Histopathological diagnosis was available for 9 cases, confirming the presence of a spongiotic dermatitis with possible associated psoriasiform skin changes.
引用
收藏
页码:447 / 450
页数:4
相关论文
共 50 条
  • [21] The addition of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors--what has time told us?
    Fabi M.R.
    Teerlink J.R.
    Current Heart Failure Reports, 2005, 2 (2) : 59 - 64
  • [22] Penile angioedema associated with the use of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers
    McCabe, John
    Stork, Christine
    Mailloux, Danielle
    Su, Mark
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (05) : 420 - 421
  • [23] A Comparative Study of the Safety and Efficacy Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on the Management of Hypertension: A Systematic Review
    Peresuodei, Tariladei S.
    Gill, Abhishek
    Orji, Chijioke
    Reghefaoui, Maiss
    Palacios, Michell Susan Saavedra
    Nath, Tuheen Sankar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [24] Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction
    Chen, Chih-Wei
    Chang, Chun-Wei
    Lin, Yi-Cheng
    Chen, Wan-Ting
    Chien, Li-Nien
    Huang, Chun-Yao
    PLOS ONE, 2023, 18 (09):
  • [25] Improved survival with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic limb-threatening ischemia
    Khan, Sikandar Z.
    O'Brien-Irr, Monica S.
    Rivero, Mariel
    Blochle, Raphael
    Cherr, Gregory S.
    Dryjski, Maciej L.
    Dosluoglu, Hasan H.
    Lukan, James
    Rowe, Vincent L.
    Harris, Linda M.
    JOURNAL OF VASCULAR SURGERY, 2020, 72 (06) : 2130 - 2138
  • [26] Comparison of Outcomes Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Myocardial Infarction: A Meta-Analysis
    Escobar, Johao
    Rawat, Anurag
    Maradiaga, Fabricio
    Isaak, Abraham K.
    Zainab, Sana
    Dari, Mohammedsefa Arusi
    Gdey, Martha Mekonen
    Khan, Areeba
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [27] Cost-effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in newly diagnosed type 2 diabetes in Germany
    Adarkwah, Charles Christian
    Gandjour, Afschin
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2010, 26 (01) : 62 - 70
  • [28] Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials
    Tocci, Giuliano
    Paneni, Francesco
    Palano, Francesca
    Sciarretta, Sebastiano
    Ferrucci, Andrea
    Kurtz, Theodore
    Mancia, Giuseppe
    Volpe, Massimo
    AMERICAN JOURNAL OF HYPERTENSION, 2011, 24 (05) : 582 - 590
  • [29] Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study
    Roy, Jason
    Shah, Nirav R.
    Wood, G. Craig
    Townsend, Raymond
    Hennessy, Sean
    JOURNAL OF CLINICAL HYPERTENSION, 2012, 14 (07) : 407 - 414
  • [30] Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease
    Qiao, Yao
    Shin, Jung-Im
    Sang, Yingying
    Inker, Lesley A.
    Secora, Alex
    Luo, Shengyuan
    Coresh, Josef
    Alexander, G. Caleb
    Jackson, John W.
    Chang, Alex R.
    Grams, Morgan E.
    MAYO CLINIC PROCEEDINGS, 2019, 94 (11) : 2220 - 2229